rcw_number stringlengths 8 12 | title stringlengths 4 590 | text stringlengths 17 193k |
|---|---|---|
69.50.561 | Advice and consultation services—Licensed cannabis businesses. | (1) The board may grant a licensee's application for advice and consultation as provided in RCW 69.50.342 (3) and visit the licensee's licensed premises in order to provide such advice and consultation. Advice and consultation services are limited to the matters specified in the request affecting the interpretation and... |
69.50.562 | Licensed cannabis businesses—Written warnings—Waiver of sanctions with no relationship to public safety—Compliance program—Penalties—Rules. | (1) The board must prescribe procedures for the following: (a) Issuance of written warnings or notices to correct in lieu of penalties, sanctions, or other violations with respect to regulatory violations that have no direct or immediate relationship to public safety as defined by the board; (b) Waiving any fines, civi... |
69.50.563 | Licensed cannabis businesses—Civil penalty—Rules. | (1) The board may issue a civil penalty without first issuing a notice of correction if: (a) The licensee has previously been subject to an enforcement action for the same or similar type of violation of the same statute or rule or has been given previous notice of the same or similar type of violation of the same stat... |
69.50.564 | Licensed cannabis businesses—Settlement agreement. | (1) This section applies to the board's issuance of administrative violations to licensed cannabis producers, processors, retailers, transporters, and researchers, when a settlement conference is held between a hearing officer or designee of the board and the cannabis licensee that received a notice of an alleged admin... |
69.50.565 | Unpaid trust fund taxes—Limited liability business entities—Liability of responsible individuals—Administrative hearing. | (1) Whenever the board determines that a limited liability business entity has collected trust fund taxes and has failed to remit those taxes to the board and that business entity has been terminated, dissolved, or abandoned, or is insolvent, the board may pursue collection of the entity's unpaid trust fund taxes, incl... |
69.50.570 | Bundled transactions—Retail sales—Subject to tax—Exception. | (1)(a) Except as provided in (b) of this subsection, a retail sale of a bundled transaction that includes cannabis product is subject to the tax imposed under RCW 69.50.535 on the entire selling price of the bundled transaction. (b) If the selling price is attributable to products that are taxable and products that are... |
69.50.575 | Cannabis health and beauty aids. | (1) Cannabis health and beauty aids are not subject to the regulations and penalties of this chapter that apply to cannabis, cannabis concentrates, or cannabis-infused products. (2) For purposes of this section, "cannabis health and beauty aid" means a product containing parts of the cannabis plant and which: (a) Is in... |
69.50.580 | Applicants for cannabis producer's, processor's, researcher's, or retailer's licenses—Signage—Public notice requirements. | (1) Applicants for a cannabis producer's, cannabis processor's, cannabis researcher's or cannabis retailer's license under this chapter must display a sign provided by the board on the outside of the premises to be licensed notifying the public that the premises are subject to an application for such license. The sign ... |
69.50.585 | Branded promotional items—Nominal value—Personal services. | (1)(a) Nothing in this chapter prohibits a producer or processor from providing retailers branded promotional items which are of nominal value, singly or in the aggregate. Such items include but are not limited to: Lighters, postcards, pencils, matches, shirts, hats, visors, and other similar items. Branded promotional... |
69.50.587 | Cannabis science task force reports—Board rules. | The liquor and cannabis board may adopt rules that address the findings and recommendations in the task force reports provided under *RCW 43.21A.735 .
[ 2019 c 277 s 4 .]
*Reviser's note: RCW 43.21A.735 expired December 31, 2022. |
69.50.601 | Pending proceedings. | (a) [(1)] Prosecution for any violation of law occurring prior to May 21, 1971 is not affected or abated by this chapter. If the offense being prosecuted is similar to one set out in Article IV of this chapter, then the penalties under Article IV apply if they are less than those under prior law. (b) [(2)] Civil seizur... |
69.50.602 | Continuation of rules. | Any orders and rules promulgated under any law affected by this chapter and in effect on May 21, 1971 and not in conflict with it continue in effect until modified, superseded or repealed.
[ 1971 ex.s. c 308 s 69.50.602 .] |
69.50.603 | Uniformity of interpretation. | This chapter shall be so applied and construed as to effectuate its general purpose to make uniform the law with respect to the subject of this chapter among those states which enact it.
[ 1971 ex.s. c 308 s 69.50.603 .] |
69.50.604 | Short title. | This chapter may be cited as the Uniform Controlled Substances Act.
[ 1971 ex.s. c 308 s 69.50.604 .] |
69.50.611 | State preemption. | The state of Washington fully occupies and preempts the entire field of setting penalties for violations of the controlled substances act. Cities, towns, and counties or other municipalities may enact only those laws and ordinances relating to controlled substances that are consistent with this chapter. Such local ordi... |
69.50.612 | State preemption—Drug paraphernalia. | (1) The state of Washington hereby fully occupies and preempts the entire field of drug paraphernalia regulation within the boundaries of the state including regulation of the use, selling, giving, delivery, and possession of drug paraphernalia, except as provided in subsection (2) of this section. Cities, towns, and c... |
69.50.700 | Expedited rule making. | The board must use expedited rule making under RCW 34.05.353 to replace the term "marijuana" with the term "cannabis" throughout Title 314 WAC.
[ 2022 c 16 s 168 .]
Intent — Finding — 2022 c 16: See note following RCW 69.50.101 . |
69.50.710 | Federal law—"Marijuana" to refer to "cannabis." | The term "marijuana" as used under federal law generally refers to the term "cannabis" used throughout the Revised Code of Washington.
[ 2022 c 16 s 169 .]
Intent — Finding — 2022 c 16: See note following RCW 69.50.101 . |
69.51.010 | Short title. | This chapter may be cited as the Controlled Substances Therapeutic Research Act.
[ 1979 c 136 s 1 .] |
69.51.020 | Legislative purpose. | The legislature finds that recent research has shown that the use of cannabis may alleviate the nausea and ill effects of cancer chemotherapy and radiology, and, additionally, may alleviate the ill effects of glaucoma. The legislature further finds that there is a need for further research and experimentation regarding... |
69.51.030 | Definitions. | As used in this chapter: (1) "Cannabis" means all parts of the plant of the genus Cannabis L., whether growing or not, the seeds thereof, the resin extracted from any part of the plant, and every compound, manufacture, salt, derivative, mixture, or preparation of the plant, its seeds, or resin; (2) "Commission" means t... |
69.51.040 | Controlled substances therapeutic research program. | (1) There is established in the commission the controlled substances therapeutic research program. The program shall be administered by the department. The commission shall promulgate rules necessary for the proper administration of the Controlled Substances Therapeutic Research Act. In such promulgation, the commissio... |
69.51.050 | Patient qualification review committee. | (1) The commission shall appoint a patient qualification review committee to serve at its pleasure. The patient qualification review committee shall be comprised of: (a) A physician licensed to practice medicine in Washington state and specializing in the practice of ophthalmology; (b) A physician licensed to practice ... |
69.51.060 | Sources and distribution of cannabis. | (1) The commission shall obtain cannabis through whatever means it deems most appropriate and consistent with regulations promulgated by the United States food and drug administration, the drug enforcement agency, and the national institute on drug abuse, and pursuant to the provisions of this chapter. (2) The commissi... |
69.51.080 | Cannabis and related products considered Schedule II substances. | (1) The enumeration of tetrahydrocannabinols, or a chemical derivative of tetrahydrocannabinols in RCW 69.50.204 as a Schedule I controlled substance does not apply to the use of cannabis, tetrahydrocannabinols, or a chemical derivative of tetrahydrocannabinols by certified patients pursuant to the provisions of this c... |
69.51A.005 | Purpose and intent. | (1) The legislature finds that: (a) There is medical evidence that some patients with terminal or debilitating medical conditions may, under their health care professional's care, benefit from the medical use of cannabis. Some of the conditions for which cannabis appears to be beneficial include, but are not limited to... |
69.51A.010 | Definitions.(Effective until June 30, 2027.) | The definitions in this section apply throughout this chapter unless the context clearly requires otherwise. (1)(a) "Authorization" means a form developed by the department that is completed and signed by a qualifying patient's health care professional and printed on tamper-resistant paper. (b) An authorization is not ... |
69.51A.030 | Acts not constituting crimes or unprofessional conduct—Health care professionals not subject to penalties or liabilities. | (1) The following acts do not constitute crimes under state law or unprofessional conduct under chapter 18.130 RCW, and a health care professional may not be arrested, searched, prosecuted, disciplined, or subject to other criminal sanctions or civil consequences or liability under state law, or have real or personal p... |
69.51A.040 | Compliance with chapter—Qualifying patients and designated providers not subject to penalties—Law enforcement not subject to liability. | The medical use of cannabis in accordance with the terms and conditions of this chapter does not constitute a crime and a qualifying patient or designated provider in compliance with the terms and conditions of this chapter may not be arrested, prosecuted, or subject to other criminal sanctions or civil consequences fo... |
69.51A.045 | Possession of plants, cannabis concentrates, useable cannabis, or cannabis-infused products exceeding lawful amount—Affirmative defense. | (1) A qualifying patient or designated provider in possession of plants, cannabis concentrates, useable cannabis, or cannabis-infused products exceeding the limits set forth in this chapter but otherwise in compliance with all other terms and conditions of this chapter may establish an affirmative defense to charges of... |
69.51A.050 | Medical cannabis, lawful possession—State not liable. | (1) The lawful possession or manufacture of medical cannabis as authorized by this chapter shall not result in the forfeiture or seizure of any property. (2) No person shall be prosecuted for constructive possession, conspiracy, or any other criminal offense solely for being in the presence or vicinity of medical canna... |
69.51A.055 | Limitations of chapter—Persons under supervision. | (1)(a) The arrest and prosecution protections established in RCW 69.51A.040 may not be asserted in a supervision revocation or violation hearing by a person who is supervised by a corrections agency or department, including local governments or jails, that has determined that the terms of this section are inconsistent ... |
69.51A.060 | Crimes—Limitations of chapter. | (1) It shall be a class 3 civil infraction to use or display medical cannabis in a manner or place which is open to the view of the general public. (2) Nothing in this chapter establishes a right of care as a covered benefit or requires any state purchased health care as defined in RCW 41.05.011 or other health carrier... |
69.51A.100 | Qualifying patient's designation of a specific designated provider—Provider's service as designated provider—Termination—Department may adopt rules. | (1) A qualifying patient may revoke his or her designation of a specific designated provider and designate a different designated provider at any time. A revocation of designation must be in writing, signed and dated, and provided to the designated provider and, if applicable, the medical cannabis authorization databas... |
69.51A.110 | Suitability for organ transplant. | A qualifying patient's medical use of cannabis as authorized by a health care professional may not be a sole disqualifying factor in determining the patient's suitability for an organ transplant, unless it is shown that this use poses a significant risk of rejection or organ failure. This section does not preclude a he... |
69.51A.120 | Parental rights or residential time—Not to be restricted. | A qualifying patient or designated provider may not have his or her parental rights or residential time with a child restricted solely due to his or her medical use of cannabis in compliance with the terms of this chapter absent written findings supported by evidence that such use has resulted in a long-term impairment... |
69.51A.130 | State and municipalities—Not subject to liability. | (1) No civil or criminal liability may be imposed by any court on the state or its officers and employees for actions taken in good faith under this chapter and within the scope of their assigned duties. (2) No civil or criminal liability may be imposed by any court on cities, towns, and counties or other municipalitie... |
69.51A.210 | Qualifying patients or designated providers—Authorization—Health care professional may include recommendations on amount of cannabis. | As part of authorizing a qualifying patient or designated provider, the health care professional may include recommendations on the amount of cannabis that is likely needed by the qualifying patient for his or her medical needs and in accordance with this section. (1) If the health care professional does not include re... |
69.51A.220 | Health care professionals may authorize medical use of cannabis—Qualifying patients under age eighteen. | (1) Health care professionals may authorize the medical use of cannabis for qualifying patients who are under the age of eighteen if: (a) The minor's parent or guardian participates in the minor's treatment and agrees to the medical use of cannabis by the minor; and (b) The parent or guardian acts as the designated pro... |
69.51A.225 | Students who qualify for the medical use of cannabis—Consumption of cannabis-infused products on school grounds. | A school district must permit a student who meets the requirements of RCW 69.51A.220 to consume cannabis-infused products on school grounds, aboard a school bus, or while attending a school-sponsored event. The use must be in accordance with school policy relating to medical cannabis use on school grounds, aboard a sch... |
69.51A.230 | Medical cannabis authorization database—Recognition cards. | (1) The department must contract with an entity to create, administer, and maintain a secure and confidential medical cannabis authorization database that allows: (a) A cannabis retailer with a medical cannabis endorsement to add a qualifying patient or designated provider and include the amount of cannabis concentrate... |
69.51A.235 | Compassionate care renewals—Rules—Effective date. | The compassionate care renewals permitted in RCW 69.51A.030 and 69.51A.230 take effect November 1, 2019. The department may adopt rules to implement these renewals and to streamline administrative functions. However, the policy established in these sections may not be delayed until the rules are adopted.
[ 2019 c 203 s... |
69.51A.240 | Unlawful actions—Criminal penalty. | (1) It is unlawful for a person to knowingly or intentionally: (a) Access the medical cannabis authorization database for any reason not authorized under RCW 69.51A.230 ; (b) Disclose any information received from the medical cannabis authorization database in violation of RCW 69.51A.230 including, but not limited to, ... |
69.51A.250 | Cooperatives—Qualifying patients or designated providers may form—Requirements—Restrictions on locations—State liquor and cannabis board may adopt rules. | (1) Qualifying patients or designated providers may form a cooperative and share responsibility for acquiring and supplying the resources needed to produce and process cannabis only for the medical use of members of the cooperative. No more than four qualifying patients or designated providers may become members of a c... |
69.51A.260 | Housing unit—No more than fifteen plants may be grown or located—Exception—Civil penalties. | (1) Notwithstanding any other provision of this chapter and even if multiple qualifying patients or designated providers reside in the same housing unit, no more than fifteen plants may be grown or located in any one housing unit other than a cooperative established pursuant to RCW 69.51A.250 . (2) Neither the producti... |
69.51A.270 | Extracting or separating cannabis resin, producing or processing any form of cannabis concentrates or cannabis-infused products—State liquor and cannabis board to adopt rules. | (1) Once the state liquor and cannabis board adopts rules under subsection (2) of this section, qualifying patients or designated providers may only extract or separate the resin from cannabis or produce or process any form of cannabis concentrates or cannabis-infused products in accordance with those standards. (2) Th... |
69.51A.280 | Topical, ingestible products—THC concentration. | Neither this chapter nor chapter 69.50 RCW prohibits a health care professional from selling or donating topical, noningestible products that have a THC concentration of less than .3 percent to qualifying patients.
[ 2015 c 70 s 35 .]
Effective date — 2015 c 70 ss 12, 19, 20, 23-26, 31, 35, 40, and 49: See note followi... |
69.51A.290 | Medical cannabis consultant certificate. | A medical cannabis consultant certificate is hereby established. (1) In addition to any other authority provided by law, the secretary of the department may: (a) Adopt rules, in accordance with chapter 34.05 RCW, necessary to implement this chapter; (b) Establish forms and procedures necessary to administer this chapte... |
69.51A.300 | Continuing education programs for health care providers. | The board of naturopathy, the board of osteopathic medicine and surgery, the Washington medical commission, and the state board of nursing shall develop and approve continuing education programs related to the use of cannabis for medical purposes for the health care providers that they each regulate that are based upon... |
69.51A.310 | Immature plants and clones, cannabis seeds—Qualifying patients and designated providers may purchase. | Qualifying patients and designated providers, who hold a recognition card and have been entered into the medical cannabis authorization database, may purchase immature plants or clones from a licensed cannabis producer as defined in RCW 69.50.101 . Qualifying patients and designated providers may also purchase cannabis... |
69.51A.900 | Short title—1999 c 2. | This chapter may be known and cited as the Washington state medical use of cannabis act.
[ 2011 c 181 s 1106 ; 1999 c 2 s 1 (Initiative Measure No. 692, approved November 3, 1998).] |
69.52.010 | Legislative findings. | The legislature finds that imitation controlled substances are being manufactured to imitate the appearance of the dosage units of controlled substances for sale to school-age youths and others to facilitate the fraudulent sale of controlled substances. The legislature further finds that manufacturers are endeavoring t... |
69.52.020 | Definitions. | Unless the context clearly requires otherwise, the definitions in this section apply throughout this chapter. (1) "Controlled substance" means a substance as that term is defined in chapter 69.50 RCW. (2) "Distribute" means the actual or constructive transfer (or attempted transfer) or delivery or dispensing to another... |
69.52.030 | Violations—Exceptions. | (1) It is unlawful for any person to manufacture, distribute, or possess with intent to distribute, an imitation controlled substance. Any person who violates this subsection shall, upon conviction, be guilty of a class C felony. (2) Any person eighteen years of age or over who violates subsection (1) of this section b... |
69.52.040 | Seizure of contraband. | Imitation controlled substances shall be subject to seizure, forfeiture, and disposition in the same manner as are controlled substances under RCW 69.50.505 .
[ 1982 c 171 s 5 .] |
69.52.045 | Seizure at rental premises—Notification of landlord. | Whenever an imitation controlled substance which is manufactured, distributed, or possessed in violation of this chapter is seized at rental premises, the law enforcement agency shall make a reasonable attempt to discover the identity of the landlord and shall notify the landlord in writing, at the last address listed ... |
69.52.050 | Injunctive action by attorney general authorized. | The attorney general is authorized to apply for injunctive action against a manufacturer or distributor of imitation controlled substances in this state.
[ 1982 c 171 s 6 .] |
69.52.060 | Injunctive or other legal action by manufacturer of controlled substances authorized. | Any manufacturer of controlled substances licensed or registered in a state requiring such licensure or registration, may bring injunctive or other action against a manufacturer or distributor of imitation controlled substances in this state.
[ 1982 c 171 s 7 .] |
69.52.070 | Violations—Juvenile driving privileges. | (1) If a juvenile thirteen years of age or older and under the age of twenty-one is found by a court to have committed any offense that is a violation of this chapter, the court shall notify the department of licensing within twenty-four hours after entry of the judgment, unless the offense is the juvenile's first offe... |
69.52.901 | Effective date—1982 c 171. | This act shall take effect on July 1, 1982.
[ 1982 c 171 s 10 .] |
69.53.010 | Unlawful use of building for drug purposes—Liability of owner or manager—Penalty. | (1) It is unlawful for any person who has under his or her management or control any building, room, space, or enclosure, either as an owner, lessee, agent, employee, or mortgagee, to knowingly rent, lease, or make available for use, with or without compensation, the building, room, space, or enclosure for the purpose ... |
69.53.020 | Unlawful fortification of building for drug purposes—Penalty. | (1) It is unlawful for any person who has under his or her management or control any building, room, space, or enclosure, either as an owner, lessee, agent, employee, or mortgagee, to knowingly allow the building, room, space, or enclosure to be fortified to suppress law enforcement entry in order to further the unlawf... |
69.53.030 | Unlawful use of fortified building—Penalty. | (1) It is unlawful for any person to use a building, room, space, or enclosure specifically designed to suppress law enforcement entry in order to unlawfully manufacture, deliver, sell, store, or give away any controlled substance under chapter 69.50 RCW, legend drug under chapter 69.41 RCW, or imitation controlled sub... |
69.55.010 | Theft of ammonia. | (1) A person who, with intent to deprive the owner or owner's agent, wrongfully obtains pressurized ammonia gas or pressurized ammonia gas solution, is guilty of theft of ammonia. (2) Theft of ammonia is a class C felony.
[ 2002 c 133 s 1 ; 2000 c 225 s 1 .]
Effective date — 2002 c 133: "This act is necessary for the i... |
69.55.020 | Unlawful storage of ammonia. | A person is guilty of the crime of unlawful storage of ammonia if the person possesses, transports, or delivers pressurized ammonia gas or pressurized ammonia gas solution in a container that (1) is not approved by the United States department of transportation to hold ammonia, or (2) was not constructed to meet state ... |
69.55.030 | Damages—Liability. | Any damages arising out of the unlawful possession of, storage of, or tampering with pressurized ammonia gas or pressurized ammonia gas solution, or pressurized ammonia gas equipment or pressurized ammonia gas solution equipment, shall be the sole responsibility of the unlawful possessor, storer, or tamperer. In no cas... |
69.57.010 | Findings. | (1) The sale of sodium nitrite is a matter of statewide and national concern as there are increasing reports about the extreme health risks of ingestion of sodium nitrite, particularly by people attempting suicide. Sodium nitrite has been promoted online as an effective method to complete suicide as it is readily avail... |
69.57.020 | Definitions. | The definitions in this section apply throughout this chapter unless the context clearly requires otherwise. (1) "Commercial business" means a business or institution, including a research institution, requiring the use of covered products as that term is defined in this section. (2) "Covered entity" means a person sel... |
69.57.030 | Restriction on sale of covered products—Labeling requirements. | A covered entity shall not: (1) Sell or transfer a covered product except to a commercial business in accordance with RCW 69.57.040 ; or (2) Sell or offer to sell, directly or indirectly, a covered product without a label notice that meets the requirements of RCW 69.57.050 .
[ 2025 c 13 s 3 .]
Effective date — 2025 c 1... |
69.57.040 | Sale or transfer of covered products to commercial businesses. | (1) A covered entity may sell or transfer a covered product to a verified commercial business if, prior to the sale or transfer of the covered product: (a) The commercial business affirms that the commercial business requires covered products, which must include the commercial business providing its employer identifica... |
69.57.050 | Labeling and shipping requirements. | (1) A covered entity shall label or ensure that a label satisfying the requirements of this section is already affixed to a covered product with the phrase "WARNING DANGER: Deadly if ingested. If ingested, seek immediate medical attention for intravenous administration of methylene blue. Ingestion of sodium nitrite, ev... |
69.57.060 | Records. | A covered entity shall retain sale and transfer records and documentation for each purchase or transfer of a covered product for three years from the date of sale or transfer.
[ 2025 c 13 s 6 .]
Effective date — 2025 c 13: See note following RCW 69.57.010 . |
69.57.070 | Violations. | (1) A covered entity that violates chapter 13, Laws of 2025 is subject to a civil penalty of $10,000 for the first violation, and a civil penalty of no more than $1,000,000 for a second or subsequent violation. (2)(a) The attorney general, prosecuting attorney within the relevant jurisdiction, or any aggrieved individu... |
69.57.080 | Consumer protection act. | The legislature finds that the practices covered by this chapter are matters vitally affecting the public interest for the purpose of applying the consumer protection act, chapter 19.86 RCW. A violation of this chapter is not reasonable in relation to the development and preservation of business and is an unfair or dec... |
69.57.900 | Short title. | This chapter may be known and cited as Tyler's law.
[ 2025 c 13 s 9 .]
Effective date — 2025 c 13: See note following RCW 69.57.010 . |
69.60.010 | Legislative findings. | The legislature of the state of Washington finds that: (1) Accidental and purposeful ingestions of solid medication forms continue to be the most frequent cause of poisoning in our state; (2) Modern treatment is dependent upon knowing the ingredients of the ingestant; (3) The imprinting of identifying characteristics o... |
69.60.020 | Definitions. | The terms defined in this section shall have the meanings indicated when used in this chapter. (1) "Commission" means the pharmacy quality assurance commission. (2) "Over-the-counter medication" means a drug that can be obtained without a prescription and is not restricted to use by prescribing practitioners. For purpo... |
69.60.030 | Identification required. | (1) No over-the-counter medication in solid dosage form may be manufactured or commercially distributed within this state unless it has clearly marked or imprinted on it an individual symbol, number, company name, words, letters, marking, or national drug code number identifying the medication and the manufacturer or d... |
69.60.040 | Imprint information—Publication—Availability. | Each manufacturer shall publish and provide to the commission printed material which will identify each current imprint used by the manufacturer and the commission shall be notified of any change. This information shall be provided by the commission to all pharmacies licensed in the state of Washington, poison control ... |
69.60.050 | Noncompliance—Contraband—Fine. | (1) Any over-the-counter medication prepared or manufactured or offered for sale in violation of this chapter or implementing rules shall be contraband and subject to seizure, in the same manner as contraband legend drugs under RCW 69.41.060 . (2) A purveyor who fails to comply with this chapter after one notice of non... |
69.60.060 | Rules. | The commission shall have authority to promulgate rules for the enforcement and implementation of this chapter.
[ 2013 c 19 s 119 ; 1989 c 247 s 6 .] |
69.60.070 | Imprinting requirements—Retailers and wholesalers. | All over-the-counter medications manufactured in, received by, distributed to, or shipped to any retailer or wholesaler in this state after January 1, 1994, shall meet the requirements of this chapter. No over-the-counter medication may be sold to a consumer in this state after January 1, 1995, unless such over-the-cou... |
69.60.080 | Exemptions—Application by manufacturer. | The commission, upon application of a manufacturer, may exempt an over-the-counter drug from the requirements of chapter 69.60 RCW on the grounds that imprinting is infeasible because of size, texture, or other unique characteristics.
[ 2013 c 19 s 120 ; 1989 c 247 s 8 .] |
69.60.090 | Implementation of federal system—Termination of state system. | Before January 1, 1994, the commission will consult with the state toxicologist to determine whether the federal government has established a legally enforceable system that is substantially equivalent to the requirements of this chapter that govern the imprinting of solid dosage form over-the-counter medication. To be... |
69.60.901 | Effective date—1993 c 135. | This act is necessary for the immediate preservation of the public peace, health, or safety, or support of the state government and its existing public institutions, and shall take effect immediately [April 30, 1993].
[ 1993 c 135 s 5 .] |
69.70.010 | Definitions. | The definitions in this section apply throughout this chapter unless the context clearly requires otherwise. (1) "Department" means the department of health. (2) "Drug manufacturer" means a facility licensed by the pharmacy quality assurance commission under chapter 18.64 RCW that engages in the manufacture of drugs or... |
69.70.020 | Donations of prescription drugs and supplies—Distribution. | (1) Any practitioner, pharmacist, medical facility, drug manufacturer, or drug wholesaler may donate prescription drugs and supplies to a pharmacy for redistribution without compensation or the expectation of compensation to individuals who meet the prioritization criteria established in RCW 69.70.040 . Donations of pr... |
69.70.030 | Immunity—Eligibility. | To be eligible for the immunity in RCW 69.70.070 , a person distributing donated prescription drugs under this chapter must: (1) Meet all requirements in RCW 69.70.050 and any applicable rules related to the return or exchange of prescription drugs or supplies adopted by the *board of pharmacy; (2) Maintain records of ... |
69.70.040 | Dispensing of donated prescription drugs and supplies—Priority given to individuals who are uninsured. | Pharmacies, pharmacists, and prescribing practitioners that elect to dispense donated prescription drugs and supplies under this chapter shall give priority to individuals who are uninsured. If an uninsured individual has not been identified as in need of available prescription drugs and supplies, those prescription dr... |
69.70.050 | Acceptance and dispensing of prescription drugs or supplies—Requirements—Recalls—Reselling—Reimbursement, related dispensing fees—Manufacturer registration. | (1) Prescription drugs or supplies may be accepted and dispensed under this chapter if all of the following conditions are met: (a) The prescription drug is in: (i) Its original sealed and tamper evident packaging; or (ii) An opened package if it contains single unit doses that remain intact; (b) The prescription drug ... |
69.70.060 | Form—Department to develop. | The department shall develop a form for persons to use when releasing prescription drugs for distribution and certifying the condition of the drugs, as provided in RCW 69.70.020 (2).
[ 2016 c 43 s 5 ; 2013 c 260 s 6 .]
Effective date — Short title — 2016 c 43: See notes following RCW 69.70.010 . |
69.70.070 | Liability. | (1) A drug manufacturer acting in good faith may not, in the absence of a finding of gross negligence, be subject to criminal prosecution or liability in tort or other civil action, for injury, death, or loss to person or property for matters relating to the donation, acceptance, or dispensing of any drug manufactured ... |
69.70.080 | Availability of access. | Access to prescription drugs and supplies under this chapter is subject to availability. Nothing in this chapter establishes an entitlement to receive prescription drugs and supplies through the program.
[ 2013 c 260 s 8 .] |
69.70.090 | Samples. | Nothing in this chapter restricts the use of samples by a practitioner during the course of the practitioner's duties at a medical facility or pharmacy.
[ 2013 c 260 s 9 .] |
69.70.100 | Resale of prescription drugs not authorized. | Nothing in this chapter authorizes the resale of prescription drugs by any person.
[ 2013 c 260 s 10 .] |
69.70.110 | Prescription drug donation—Rules. | The pharmacy quality assurance commission may adopt rules to allow the safe donation of prescription drugs under this chapter including, but not limited to, allowing pharmacy to pharmacy donation of unexpired prescription drug stock.
[ 2020 c 264 s 2 .] |
69.70.900 | Effective date. | This act takes effect July 1, 2014.
[ 2013 c 260 s 12 .] |
69.75.010 | Definitions. | The definitions in this section apply throughout this chapter unless the context clearly requires otherwise. (1) "Common carrier" means any person who holds himself or herself out to the general public as a provider for hire of the transportation by water, land, or air of merchandise, whether or not the person actually... |
69.75.020 | Retail sales—Proof of age from purchaser—Unlawful acts, exceptions—Penalties. | (1) A person making a retail sale of a finished drug product containing any quantity of dextromethorphan must require and obtain proof of age from the purchaser before completing the sale, unless from the purchaser's outward appearance the person making the sale would reasonably presume the purchaser to be twenty-five ... |
69.75.030 | List of products containing dextromethorphan, trade association representing manufacturers to supply. | The trade association representing manufacturers of dextromethorphan shall supply to the pharmacy quality assurance commission and requesting licensed retailers an initial list of products containing dextromethorphan that its members market. This list shall be updated on an annual basis. The trade association represent... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.